Home Alzheimer’s Disease FDA Grants Fast Track Designation to Balstilimab/Zalifrelimab Combination for Cervical Cancer

FDA Grants Fast Track Designation to Balstilimab/Zalifrelimab Combination for Cervical Cancer

The FDA granted fast track designation for investigation of balstilimab in combination with zalifrelimab for the treatment of patients with relapsed or refractory metastatic cervical cancer, according to Agenus, the agent’s developer.1

The designation was based on comprehensive data that supported the potential for balstilimab and zalifrelimab. 

“We are pleased that balstilimab and zalifrelimab have been granted fast track designation by FDA in recognition of the high unmet medical need in second line cervical cancer,” said Jennifer Buell, PhD, president and COO of Agenus, said in a press release. “We are excited about the prospect of making these novel agents available to women who suffer from metastatic cervical cancer. We look forward to continuing to work with FDA as we advance new treatment options for patients with cancer.”

Following this regulatory action, the…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Parasite found in undercooked meat linked with risk of rare brain cancer

submitted by /u/Meat_Mithkabob Continue Reading to the Source

Living up to expectations : braincancer

Hey everyone!I wrote a little something about some of the comments you often hear from others and how sometimes you feel like you need...

My Brain Tumor Taught Me To Shift My Perspective on These 5 Things

submitted by /u/andrewjoegeorge Continue Reading to the Source

Recent Comments